S
LABD icon

Steadtrust’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Steadtrust’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,000
Closed -$74.8K – 126
2025
Q2 		$74.8K Buy
+1,000
New +$88.4K 0.06% 113

Other funds holding LABD

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return

Steadtrust's LABD Position: Q3 2025 in Review

Steadtrust sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q3 2025, closing a stake of 1,000 shares — an estimated $74.8K sold.

Steadtrust first reported a position in LABD in Q2 2025 and held it in 1 quarter. The position peaked at $74.8K in Q2 2025. 18 funds tracked by Wall St. Rank hold LABD as of Q3 2025.

  • Steadtrust reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q3 2025 after selling out during the quarter.
  • Steadtrust sold 1,000 Direxion Daily S&P Biotech Bear 3X ETF shares in Q3 2025, an estimated $74.8K.
  • Steadtrust first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q2 2025 and held it in 1 quarter.
  • Steadtrust's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $74.8K in Q2 2025.
  • 18 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q3 2025.

Based on Steadtrust's 13F filing for Q3 2025, filed 2 Dec 2025.